reglab/housing_qa huggingface dataset:
MD. Health - General Code Ann. §  13-3107 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 31 - Overdose Response Program|Section 13-3107 - Immunity -- Not Deemed to Be Practicing Medicine, Registered Nursing, or Pharmacy

    (a)    An individual who, in accordance with this subtitle, is administering naloxone to an individual experiencing or believed by the individual to be experiencing an opioid overdose may not be considered to be practicing:        (1)    Medicine for the purposes of Title 14 of the Health Occupations Article; or        (2)    Registered nursing for the purposes of Title 8 of the Health Occupations Article.    (b)    An employee or volunteer of a private or public entity who, in accordance with this subtitle, provides naloxone to an individual who has received education and training in opioid overdose recognition and response in accordance with a standing order may not be considered to be practicing:        (1)    Medicine for the purposes of Title 14 of the Health Occupations Article;        (2)    Registered nursing for the purposes of Title 8 of the Health Occupations Article; or        (3)    Pharmacy for the purposes of Title 12 of the Health Occupations Article.    (c)    A licensed health care provider who prescribes or dispenses naloxone in accordance with this subtitle may not be subject to any disciplinary action by the appropriate licensing health occupations board under the Health Occupations Article solely for the act of prescribing or dispensing naloxone.
MD. Health - General Code Ann. §  13-3108 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 31 - Overdose Response Program|Section 13-3108 - Immunity -- Individuals and Medical Providers

    (a)    An individual who administers naloxone to an individual who is or in good faith is believed to be experiencing an opioid overdose shall have immunity from liability under §§ 5–603 and 5–629 of the Courts Article.    (b)    A cause of action may not arise against any licensed health care provider with prescribing authority or pharmacist for any act or omission when the health care provider with prescribing authority or pharmacist in good faith prescribes or dispenses naloxone and the necessary paraphernalia for the administration of naloxone to an individual under § 13–3106 of this subtitle.    (c)    This subtitle may not be construed to create a duty on any individual to:        (1)    Obtain education and training from an authorized private or public entity under this subtitle, and an individual may not be held civilly liable for failing to obtain education and training from an authorized private or public entity under this subtitle; or        (2)    Administer naloxone to an individual who is experiencing or believed by the individual to be experiencing an opioid overdose.
MD. Health - General Code Ann. §  13-3109 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 31 - Overdose Response Program|Section 13-3109 - Exemption From Permit Requirements

    A person who dispenses naloxone in accordance with this subtitle is exempt from any laws that require a person to maintain a permit to dispense prescription drugs.
MD. Health - General Code Ann. §  13-3201 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Disorders Council|Section 13-3201 - "Council" Defined [Subtitle Subject to Abrogation]

    // EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 //    In this subtitle, “Council” means the Virginia I. Jones Alzheimer’s Disease and Related Disorders Council.
MD. Health - General Code Ann. §  13-3202 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Disorders Council|Section 13-3202 - Council Established [Subtitle Subject to Abrogation]

    // EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 //    There is a Virginia I. Jones Alzheimer’s Disease and Related Disorders Council.
MD. Health - General Code Ann. §  13-3203 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Disorders Council|Section 13-3203 - Membership [Subtitle Subject to Abrogation]

    // EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 //    (a)    The Council consists of the following members:        (1)    One member of the Senate of Maryland, appointed by the President of the Senate;        (2)    One member of the House of Delegates, appointed by the Speaker of the House;        (3)    The Secretary of Health, or the Secretary’s designee;        (4)    The Secretary of Aging, or the Secretary’s designee;        (5)    The Executive Director of the Alzheimer’s Association, Greater Maryland Chapter, or the Executive Director’s designee;        (6)    The President of the Alzheimer’s Association, National Capital Area Chapter, or the President’s designee; and        (7)    The following members, appointed by the Governor:            (i)    Seven health care professionals with relevant professional experience;            (ii)    Three human service professionals with relevant professional experience;            (iii)    One elder law attorney with relevant professional experience;            (iv)    Two research professionals with relevant professional experience;            (v)    Two family caregivers of individuals with Alzheimer’s disease or a related disorder; and            (vi)    At the recommendation of the Council, any other member necessary to fulfill the duties of the Council.    (b)    To the extent practicable, the members appointed to the Council shall reflect the geographic, racial, ethnic, cultural, and gender diversity of the State.
MD. Health - General Code Ann. §  13-3204 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Disorders Council|Section 13-3204 - Chair; Compensation; Reimbursement for Expenses [Subtitle Subject to Abrogation]

    // EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 //    (a)    The members of the Council shall select the chair of the Council.    (b)    A member of the Council:        (1)    May not receive compensation as a member of the Council; but        (2)    Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
MD. Health - General Code Ann. §  13-3205 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Disorders Council|Section 13-3205 - Staff [Subtitle Subject to Abrogation]

    // EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 //    (a)    The Department, with assistance from the Department of Aging, shall provide staff support for the Council.    (b)    The Department may request staffing assistance from public health entities with an interest in the duties of the Council.
MD. Health - General Code Ann. §  13-3206 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Disorders Council|Section 13-3206 - Duties [Subtitle Subject to Abrogation]

    // EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 //    The Council shall:        (1)    Update the State Plan on Alzheimer’s Disease and Related Disorders and advocate for the State Plan;        (2)    (i)    Examine the needs of individuals with Alzheimer’s disease and related disorders and their caregivers; and            (ii)    Identify methods through which the State can most effectively and efficiently assist in meeting those needs;        (3)    Advise the Governor and the General Assembly on policy, funding, regulatory, and other issues related to individuals with Alzheimer’s disease and related disorders and their caregivers; and        (4)    Develop and promote strategies to encourage brain health and reduce cognitive decline.
MD. Health - General Code Ann. §  13-3207 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Disorders Council|Section 13-3207 - Report [Subtitle Subject to Abrogation]

    // EFFECTIVE UNTIL SEPTEMBER 30, 2024 PER CHAPTERS 410 AND 411 OF 2019 //    On or before September 1 each year, the Council shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on the activities and recommendations of the Council.
MD. Health - General Code Ann. §  13-3301.1 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3301.1 - Legislative Intent

    The General Assembly intends that the programs implemented in accordance with this subtitle yield a successful but consumer–friendly medical cannabis industry in the State to provide patients affordable and adequate access to medical cannabis.
MD. Health - General Code Ann. §  13-3303.1 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3303.1 - Compassionate Use Fund

    (a)    In this section, “Compassionate Use Fund” means the Natalie M. LaPrade Medical Cannabis Compassionate Use Fund.    (b)    There is a Natalie M. LaPrade Medical Cannabis Compassionate Use Fund.    (c)    (1)    The Commission shall:            (i)    Administer the Compassionate Use Fund; and            (ii)    Subject to paragraph (2) of this subsection, set fees in an amount necessary to provide revenues for the purposes of the Compassionate Use Fund.        (2)    The Commission may not impose the fees established under paragraph (1)(ii) of this subsection on a licensed medical cannabis grower, processor, or dispensary during the 2 years immediately following the issuance of a license under this subtitle.    (d)    The purpose of the Compassionate Use Fund is to provide access to medical cannabis for individuals enrolled in the Maryland Medical Assistance Program or in the Veterans Affairs Maryland Health Care System.    (e)    (1)    The Compassionate Use Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.        (2)    The State Treasurer shall hold the Compassionate Use Fund separately, and the Comptroller shall account for the Compassionate Use Fund.        (3)    The Compassionate Use Fund shall be invested and reinvested in the same manner as other State funds, and any investment earnings shall be retained to the credit of the Compassionate Use Fund.        (4)    The Compassionate Use Fund shall be subject to an audit by the Office of Legislative Audits as provided for in § 2–1220 of the State Government Article.        (5)    The Comptroller shall pay out money from the Compassionate Use Fund as directed by the Commission.    (f)    No part of the Compassionate Use Fund may revert or be credited to:        (1)    The General Fund of the State; or        (2)    Any other special fund of the State.    (g)    Expenditures from the Compassionate Use Fund may be made only in accordance with the State budget.    (h)    (1)    The Commission shall establish a program to allow eligible individuals enrolled in the Maryland Medical Assistance Program or in the Veterans Affairs Maryland Health Care System to:            (i)    Obtain medical cannabis from a licensed dispensary at a reduced cost; and            (ii)    Reimburse a licensed dispensary for the cost of the medical cannabis dispensed to an eligible individual under the program from the Compassionate Use Fund.        (2)    The Commission shall adopt regulations to implement this subsection.
MD. Health - General Code Ann. §  13-3304.1 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3304.1 - Registration to Purchase Medical Cannabis for Purpose of Conducting Research Project Relating to Medical Uses, Properties, or Composition of Cannabis

    (a)    (1)    An institution of higher education, a related medical facility, or an affiliated biomedical research firm may file with the Commission a registration to purchase medical cannabis for the purpose of conducting a bona fide research project relating to the medical uses, properties, or composition of cannabis.        (2)    A registration filed under paragraph (1) of this subsection shall include:            (i)    The name of the primary researcher;            (ii)    The expected duration of the research; and            (iii)    The primary objectives of the research.        (3)    A registration filed under paragraph (1) of this subsection shall remain valid until there is a change in the research project or a withdrawal of the registration.    (b)    An academic research representative may purchase medical cannabis from a licensed dispensary.    (c)    An academic research representative may not be penalized or arrested under State law for acquiring, possessing, or dispensing cannabis, products containing cannabis, related supplies, or educational materials for use in a bona fide research project relating to the medical uses, properties, or composition of cannabis.    (d)    The Commission may adopt regulations to implement this section.
MD. Health - General Code Ann. §  13-3305 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3305 - Reports by Commission

    On or before January 1 each year, the Commission shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on:        (1)    Providers certified under this subtitle; and        (2)    The amount sold, by condition treated, and average consumer price for medical cannabis products provided in accordance with this subtitle.
MD. Health - General Code Ann. §  13-3305.1 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3305.1 - Individuals Prohibited From Ownership

    (a)    In this section, “owner” includes any type of owner or beneficiary of a business entity, including an officer, a director, a principal employee, a partner, an investor, a stockholder, or a beneficial owner of the business entity and, notwithstanding any other provision of this subtitle, a person having any ownership interest regardless of the percentage of ownership interest.    (b)    Except as provided in subsection (c) of this section, a constitutional officer or a secretary of a principal department of the Executive Branch of the State government may not:        (1)    Be an owner or an employee of any business entity that holds a license under this subtitle; or        (2)    Have an official relationship to a business entity that holds a license under this subtitle.    (c)    A constitutional officer or a secretary of a principal department of the Executive Branch of the State government may remain an owner or an employee of a business entity that holds a license under this subtitle if the constitutional officer or secretary was an owner or employee of the business entity before the constitutional officer’s election or appointment or the secretary’s appointment.    (d)    A former member of the General Assembly, for the 1–year period immediately after the member leaves office, may not:        (1)    Be an owner or an employee of any business entity that holds a license under this subtitle; or        (2)    Have an official relationship with a business entity that holds a license under this subtitle.
MD. Health - General Code Ann. §  13-3305.2 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3305.2 - Study of Market With Respect to Assistance of Minorities and Women in Medical Cannabis Industry

    (a)    The Commission, in consultation with the certification agency as defined in § 14–301 of the State Finance and Procurement Article, the Governor’s Office of Small, Minority, and Women Business Affairs, and the Office of the Attorney General, shall:        (1)    Evaluate a study of the medical cannabis industry and market to determine whether there is a compelling interest to implement remedial measures, including the application of the State Minority Business Enterprise Program under Title 14, Subtitle 3 of the State Finance and Procurement Article or a similar program, to assist minorities and women in the medical cannabis industry;        (2)    Evaluate race–neutral programs or other methods that may be used to address the needs of minority and women applicants and minority and women–owned businesses seeking to participate in the medical cannabis industry; and        (3)    Submit emergency regulations, in accordance with Title 10, Subtitle 1 of the State Government Article, to implement remedial measures, if necessary and to the extent permitted by State and federal law, based on the findings of the study evaluated under item (1) of this subsection.    (b)    The Commission may report to the General Assembly, in accordance with § 2–1257 of the State Government Article, any information that the Commission determines to be necessary to the consideration, development, or implementation of any remedial measures required under this section.
MD. Health - General Code Ann. §  13-3305.3 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3305.3 - Required Affidavit to Be Submitted With Licensing Application

    A person that applies for licensure under this subtitle shall submit with the application for licensure an affidavit attesting to:        (1)    The number of minority and women owners of the applicant;        (2)    The ownership interest of any minority and women owners of the applicant;        (3)    The number of minority and women employees of the applicant; and        (4)    Any other information considered necessary by the Commission.
MD. Health - General Code Ann. §  13-3308 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3308 - Dispensary Agents

    (a)    A dispensary agent shall:        (1)    Be at least 21 years old;        (2)    Be registered with the Commission before the agent may volunteer or work for a dispensary; and        (3)    Obtain a State and national criminal history records check in accordance with § 13–3312 of this subtitle.    (b)    A dispensary shall apply to the Commission for a registration card for each dispensary agent by submitting the name, address, and date of birth of the agent.    (c)    (1)    Within 1 business day after a dispensary agent ceases to be associated with a dispensary, the dispensary shall:            (i)    Notify the Commission; and            (ii)    Return the dispensary agent’s registration card to the Commission.        (2)    On receipt of a notice described in paragraph (1) of this subsection, the Commission shall:            (i)    Immediately revoke the registration card of the dispensary agent; and            (ii)    If the registration card was not returned to the Commission, notify the Department of State Police.    (d)    The Commission may register an individual who has been convicted of a felony drug offense as a dispensary agent unless:        (1)    Except as provided in item (2) of this subsection, the individual submitted an application under subsection (b) of this section earlier than 7 years after the individual satisfied the sentence imposed for the conviction, including parole, probation, or mandatory supervision;        (2)    The individual has been convicted of a violation of § 5–612 or § 5–613 of the Criminal Law Article, regardless of whether the individual has satisfactorily completed the sentence for the offense; or        (3)    The Commission finds a substantial reason to deny the registration.
MD. Health - General Code Ann. §  13-3310 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3310 - Processor Agents

    (a)    A processor agent shall:        (1)    Be at least 21 years old;        (2)    Be registered with the Commission before the agent may volunteer or work for a processor; and        (3)    Obtain a State and national criminal history records check in accordance with § 13–3312 of this subtitle.    (b)    A processor shall apply to the Commission for a registration card for each processor agent by submitting the name, address, and date of birth of the agent.    (c)    (1)    Within 1 business day after a processor agent ceases to be associated with a processor, the processor shall:            (i)    Notify the Commission; and            (ii)    Return the processor agent’s registration card to the Commission.        (2)    On receipt of a notice described in paragraph (1) of this subsection, the Commission shall:            (i)    Immediately revoke the registration card of the processor agent; and            (ii)    If the registration card was not returned to the Commission, notify the Department of State Police.    (d)    The Commission may register an individual who has been convicted of a felony drug offense as a processor agent unless:        (1)    Except as provided in item (2) of this subsection, the individual submitted an application under subsection (b) of this section earlier than 7 years after the individual satisfied the sentence imposed for the conviction, including parole, probation, or mandatory supervision;        (2)    The individual has been convicted of a violation of § 5–612 or § 5–613 of the Criminal Law Article, regardless of whether the individual has satisfactorily completed the sentence for the offense; or        (3)    The Commission finds a substantial reason to deny the registration.
MD. Health - General Code Ann. §  13-3311 (2021)
2021 Maryland Statutes|Health - General|Title 13 - Miscellaneous Health Care Programs|Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission|Section 13-3311 - Independent Testing Laboratory

    (a)    The Commission shall register at least one private independent testing laboratory to test cannabis and products containing cannabis that are to be sold in the State.    (b)    To be registered as an independent testing laboratory, a laboratory shall:        (1)    Meet the application requirements established by the Commission;        (2)    Pay any applicable fee required by the Commission; and        (3)    Meet the standards and requirements for accreditation, inspection, and testing established by the Commission.    (c)    The Commission shall adopt regulations that establish:        (1)    The standards and requirements to be met by an independent laboratory to obtain a registration;        (2)    The standards of care to be followed by an independent testing laboratory;        (3)    The initial and renewal terms for an independent laboratory registration and the renewal procedure; and        (4)    The bases and processes for denial, revocation, and suspension of a registration of an independent testing laboratory.    (d)    The Commission may inspect an independent testing laboratory registered under this section to ensure compliance with this subtitle.